The effectiveness of levetiracetam in the treatment of neuropathic pain;Eficacia del levetiracetam en el tratamiento del dolor neuropático

Revista de Neurologia

Volumn 53, Issue 2, 2011, Pages 65-72

  del Pozo, Esperanza ^a   Pereira Pérez, Elisa ^a   González Contreras, Luis G ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

Anticonvulsants; Levetiracetam; Neuropathic pain; Painful neuropathies; Randomized controlled trial; Systematic review

Indexed keywords

ETIRACETAM;

ARTICLE; DRUG EFFICACY; HUMAN; NEUROPATHIC PAIN; PERIPHERAL NEUROPATHY; TREATMENT OUTCOME;

EID: 79960682146     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.5302.2011141     Document Type: Article

References (38)

1. Merskey H, Bogduk N. Classification of chronic pain. Seattle: IASP Press; 1997.
2. Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, et al. Redefinition of neuropathic pain and a grading system for clinical use: consensus statement on clinical and research diagnostic criteria. Neurology 2008; 70: 1630-5.
3. Costigan M, Scholz J, Woolf CJ. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci 2009; 32: 1-32.
4. Haanpää ML, Backonja MM, Bennett MI, Bouhassira D, Cruccu G, Hansson PT, et al. Assessment of neuropathic pain in primary care. Am J Med 2009; 122 (Suppl 10): S13-21.
5. Itza-Santos F, Zarza-Luciáñez D, Salinas J, Gómez-Sancha F, Bathal-Gaude H. Síndrome de atrapamiento del nervio pudendo. Rev Neurol 2010; 50: 157-66.
6. Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet 2006; 367: 1618-25.
7. Woolf CJ. Dissecting out mechanisms responsible for peripheral neuropathic pain: implications for diagnosis and therapy. Life Sci 2004; 74: 2605-10.
8. Caviedes BE, Herranz JL. Avances en la fisiopatología y en el tratamiento del dolor neuropático. Rev Neurol 2002; 35: 1037-48.
9. Mimenza-Alvarado AJ, Muñiz-Álvarez JC, Estañol-Vidal B, Téllez-Zenteno JF, García-Ramos G. Neuropatías dolorosas: fisiopatología y tratamiento. Rev Neurol 2004; 39: 364-70.
10. Scholz J, Wolf CJ. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 2007; 10: 1361-8.
11. Del Pozo E. Fisiopatología del dolor neuropático. In Gálvez-Mateos R, ed. Manual práctico de dolor neuropático. Barcelona: Elsevier; 2010. p. 15-33.
12. Pardo-Fernández J, Gutiérrez-Rivas E, Montero-Homs J, Navarro C. Tratamiento del dolor neuropático en las consultas de neurología. Estudio PREVADOL. Rev Neurol 2006; 42: 451-4.
13. Blom S. Trigeminal neuralgia: its treatment with a new anticonvulsant drug (G32883). Lancet 1962; 1: 839-40.
14. Wiffen PJ, McQuay HJ, Edwards J, Moore RA. Gabapentin for acute and chronic pain. Cochrane Database Syst Rev 2005; 3: CD005452.
15. Horga de la Parte JF, Horga-Hernández A. Pregabalina. Aportaciones de los ligandos α2δ de canales de calcio en el tratamiento de la epilepsia y el dolor neuropático. Rev Neurol 2006; 42: 223-37.
16. Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev 2009; 3: CD007076.
17. Fenollosa-Vázquez P, Canós-Verdecho MA, Núñez-Cornejo C, Pallarés-Delgado J. Eficacia y tolerancia de la oxcarbacepina en dolor neuropático crónico: estudio de 40 casos. Rev Neurol 2005; 40: 711-5.
18. López-Trigo J, Ortiz-Sánchez P, Blanco-Hernández T. Zonisamida y dolor neuropático. Rev Neurol 2007; 45: 429-32.
19. Ficha técnica del levetiracetam (Keppra ®). Madrid: Agencia Española de Medicamentos y Productos Sanitarios; 2007.
20. Herranz JL. Levetiracetam en niños y adolescentes con epilepsia. Rev Neurol 2003; 37: 558-60.
21. Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci U S A 2004; 101: 9861-6.
22. Ardid D, Lamberty Y, Alloui A, Coudore-Civiale MA, Klitgaard H, Eschalier A. Antihyperalgesic effect of levetiracetam in neuropathic pain models in rats. Eur J Pharmacol 2003; 473: 27-33.
23. Beyreuther B, Callizot N, Stöhr T. Antinociceptive efficacy of lacosamide in a rat model for painful diabetic neuropathy. Eur J Pharmacol 2006; 539: 64-70.
24. Ozcan M, Ayar A, Canpolat S, Kutlu S. Antinociceptive efficacy of levetiracetam in a mice model for painful diabetic neuropathy. Acta Anaesthesiol Scand 2008; 52: 926-30.
25. Enggaard TP, Klitgaard NA, Sindrup SH. Specific effect of levetiracetam in experimental human pain models. Eur J Pain 2006; 10: 193-8.
26. Centre for Evidence-Based Phyisotherapy. PEDro scale. Sydney: Centre for Evidence-Based Phyisotherapy; 1999. URL: http://www.pedro.org.au. [30.01.2011].
27. Rowbotham MC, Manville NS, Ren J. Pilot tolerability and effectiveness study of levetiracetam for postherpetic neuralgia. Neurology 2003; 61: 866-7.
28. Price MJ. Levetiracetam in the treatment of neuropathic pain: three case studies. Clin J Pain 2004; 20: 33-6.
29. Dunteman ED. Levetiracetam as an adjunctive analgesic in neoplastic plexopathies: case series and commentary. J Pain Palliat Care Pharmacother 2005; 19: 35-43.
30. Jorns TP, Johnston A, Zakrzewska JM. Pilot study to evaluate the efficacy and tolerability of levetiracetam (Keppra) in treatment of patients with trigeminal neuralgia. Eur J Neurol 2009; 16: 740-4.
31. Hamza MS, Anderson DG, Snyder JW, Deschner S, Cifu DX. Effectiveness of levetiracetam in the treatment of lumbar radiculopathy: an open-label prospective cohort study. PM R 2009; 1: 335-9.
32. Vilholm OJ, Cold S, Rasmussen L, Sindrup SH. Effect of levetiracetam on the postmastectomy pain syndrome. Eur J Neurol 2008; 15: 851-7.
33. Finnerup NB, Grydehøj J, Bing J, Johannesen IL, Biering-Sørensen F, Sindrup SH, et al. Levetiracetam in spinal cord injury pain: a randomized controlled trial. Spinal Cord 2009; 47: 861-7.
34. Rossi S, Mataluni G, Codecà C, Fiore S, Buttari F, Musella A, et al. Effects of levetiracetam on chronic pain in multiple sclerosis: results of a pilot, randomized, placebo-controlled study. Eur J Neurol 2009; 16: 360-6.
35. Holbech JV, Otto M, Bach FW, Jensen TS, Sindrup SH. The anticonvulsant levetiracetam for the treatment of pain in polyneuropathy: a randomized, placebo-controlled, cross-over trial. Eur J Pain 2010; Dec 21. [Epub ahead of print].
36. European Medicines Agency. Guideline on clinical medicinal products intended for the treatment of neuropathic pain. London: EMEA; 2007.
37. Luo ZD, Chaplan SR, Higuera ES, Sorkin LS, Stauderman KA, Williams ME, et al. Upregulation of dorsal root ganglion α2δ calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats. J Neurosci 2001; 21: 1868-75.
38. Luo ZD, Calcutt NA, Higuera ES, Valder CR, Song YH, Svensson CI, et al. Injury type-specific calcium channel α2δ-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. J Pharmacol Exp Ther 2002; 303: 1199-205.